PharmTech Europe, Weekly Alert
Having trouble viewing this e-mail? CLICK HERE

PharmTech Europe
02 April 2019

PHARMTECH.COM

CURRENT ISSUE

SUBSCRIBE

FORWARD

twitter twitter
advertisement

Top Stories

Difficult to Swallow? ABPI Requests Temporary Ban on Drug Exports Amid Fears of a 'No-Deal' Brexit

ABPI has asked for a temporary ban to be put in place on drug exports by wholesalers to protect the National Health Service (NHS) from potential shortages in a 'no-deal' Brexit scenario.
/ read more /


Thermo Fisher Scientific to Acquire Brammer Bio

A $1.7-billion acquisition of CDMO Brammer Bio establishes Thermo Fisher Scientific in viral vector manufacturing.
/ read more /



advertisement

advertisement

Industry News

Valitacell, Solentim Funded for Biologics and Cell Therapy Development

Valitacell, Solentim, and Microcoat were awarded EUR 3.5 million (US$4 million) to produce an integrated platform to deposit, culture, profile, and select optimal cells for biologic drug manufacturing.
/ read more /


Continuous Peptide Manufacturing Process is a New Alternative to Batch Manufacturing

A continuous peptide manufacturing process invented by Swedish Biomimetics 3000 Ltd is a platform technology also applicable to other solid-phase chemical processes, such as chromatography.
/ read more /


More Industry News

advertisement

Subscribe

Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.

subscription offers
subscribe

Regulatory News

EMA Answers Brexit Questions

The agency has published a Q&A document to answer questions about what EMA is doing to prevent medicine shortages during Brexit.
/ read more /


FDA Gives Guidance on Pediatric Information in Labeling

The agency published guidance on how to determine the placement and content of pediatric information in the labeling of drugs and biologics.
/ read more /


More Regulatory News

advertisement


Bio/Pharma News

MaSTherCell Announces New Commercial Manufacturing Facility for Cell and Gene Therapies

Belgium-based CDMO MaSTherCell will expand its European manufacturing capacity for cell and gene therapy products by setting up a new facility in Belgium.
/ read more /


 

Mogrify Receives Thousands in Funding from Innovate UK to Progress Regenerative Cell Therapies

Cell Mogrify (Mogrify), has been granted funding by the UK's innovation agency, Innovate UK, to accelerate regenerative cell therapies.
/ read more /


More Bio/Pharma News

Supplier News

Clinical Water Purification System Gets Digital Update

MilliporeSigma added a new cloud-based, remote lab water service and monitoring capability to its Milli-Q CLX 7000 clinical water purification system.
/ read more /


 

Lonza Strengthens Cell Capabilities

The company has launched a comprehensive portfolio of custom cell biology solutions and a new cell-line engineering technology.
/ read more /


More Supplier News

FEATURED TOPICS

ANALYTICS

Key Considerations in Stability Testing

Harmonization of best practices and regulatory requirements will enable developers to find the best stability testing approach.
/ read more /

 

DOSAGE FORMS

Assuring the Safe Handling of Potent APIs, Intermediates, and Solid-Dosage Drugs

Containment valves and smart monitoring can keep employees safe and improve manufacturing efficiency when handling potent APIs, intermediates, and solid-dosage drugs.
/ read more /

OUTSOURCING

Monoplant: Advantages of a Dedicated Facility

A monoplant may offer greater supply security and flexibility for specialist medicines.
/ read more /

EXCIPIENTS

Strategic Screening for Solubility Solutions

Understanding the API, delivery mechanism, and excipient functionality is essential to solving drug solubility challenges.
/ read more /


Events

2019 ISPE Europe Annual Conference

Dublin, Ireland

1–4 April 2019

POWTECH 2019

Nuremberg, Germany

9–11 April 2019

APACT '19

Chester, UK

30 April–2 May 2019


more events

eBOOKS

Laboratory Best Practices 2018 eBook

The editors explore new tools for bio/pharma lab studies—such as robotics, augmented reality, and advanced instrumentation—as well as best practices for method development, multiple attribute monitoring, lab mixers, and raw material testing.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise